z-logo
Premium
Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis
Author(s) -
Nielsen Valdemar Wendelboe,
Lund Tamara Theresia,
Gniadecki Robert,
Olsen Rasmus Huan,
Nissen Christoffer Valdemar,
Schwensen Jakob Ferløv Baselius,
Thomsen Simon Francis
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14258
Subject(s) - biosimilar , medicine , adalimumab , psoriasis , dermatology , disease

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom